Generex Biotechnology partners with Olaregen Therapeutix

Generex Biotechnology Corporation has announced that its partially, soon to be fully-owned subsidiary, Olaregen Therapeu...

January 4, 2019 | Friday | News
AstraZeneca’s Bevespi Aerosphere approved in the EU

AstraZeneca has announced that the European Commission (EC) has approved Bevespi Aerosphere (glycopyrronium/formote...

January 3, 2019 | Thursday | News
ImaginAb Announces Strengthening of Board and Executive Leadership Team

ImaginAb,  a clinical stage immuno-oncology imaging company has announced the appointment of Friedhelm Blobel, Ph.D...

January 3, 2019 | Thursday | News
Correvio Announces Chief Executive Officer Succession Plan

Correvio Pharma Corp, a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs h...

January 3, 2019 | Thursday | News
USFDA approves Portola Pharmaceuticals’ Andexxa®

Portola Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s ...

January 3, 2019 | Thursday | News
FDA approves Sanofi & MSD’s VAXELIS™

The U.S. Food and Drug Administration has approved VAXELIS™ (Diphtheria and Tetanus Toxoids and Acellular Pertussi...

January 3, 2019 | Thursday | News
AstraZeneca announces phase III trials for roxadustat

AstraZeneca has announced that the Phase III OLYMPUS and ROCKIES trials for roxadustat each met their primary efficacy e...

January 3, 2019 | Thursday | News
AI predicts cancer patients’ symptoms

Doctors could get a head start treating cancer thanks to new AI developed at the University of Surrey that is able to pr...

January 2, 2019 | Wednesday | News
Alexion receives early FDA approval For ULTOMIRIS

Alexion Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved ULTOMIRIS&trad...

January 2, 2019 | Wednesday | News
PolarityTE registers OsteoTE™ with USFDA

PolarityTE, Inc., a commercial-stage biotechnology company focused on transforming the lives of patients by discovering,...

January 2, 2019 | Wednesday | News
George A. Williams to work as 123rd President of the AAO

George A. Williams, M.D, today begins his term as the 123rd president of the American Academy of Ophthalmology (AAO). Dr...

January 1, 2019 | Tuesday | News
Ocular Therapeutix Announces Completion of Debt Refinancing

Ocular Therapeutix, a biopharmaceutical company focused on the formulation, development, and commercialization of innova...

January 1, 2019 | Tuesday | News
Innovus Pharma announces $3.17 million private placement

Innovus Pharmaceuticals, an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effectiv...

January 1, 2019 | Tuesday | News
Nuvo Pharma completes acquisition of Aralez Pharma

Nuvo Pharmaceuticals Inc. a globally focused, Canadian healthcare company with a portfolio of commercial products today ...

January 1, 2019 | Tuesday | News
Apellis Pharmaceuticals’ APL-2 receives orphan drug designation from the FDA

Apellis Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on the development of novel therap...

January 1, 2019 | Tuesday | News
Spirulina extract may provide new therapeutic to fight hypertension: Research

According to a new research by researchers from the Vascular Physiopathology Laboratory of the IRCCS Neuromed in Pozzill...

January 1, 2019 | Tuesday | News
Sistema and VTB to create a major pharmaceuticals holding

Sistema PJSFC (“Sistema”), a publicly traded diversified Russian holding company, announces it has acquired ...

December 31, 2018 | Monday | News
Better mouse model built to enable precision-medicine research for Alzheimer's: NIH

According to a study funded by the National Institute on Aging (NIA), part of the National Institutes of Health, incorpo...

December 31, 2018 | Monday | News